NDC 53002-6290
Lorazepam 2 mg tablet
On the label: RPK Pharmaceuticals, Inc.. It's repackaged: RPK Pharmaceuticals, Inc. rebottles it from Leading Pharma, LLC's NDC 69315-906.
Where the pills inside were made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Leading Pharma, LLC | Fairfield, NJ, United States | Makes it | Problems found, fixed voluntarilyOct 21, 2024 · 13 inspections |
Repackaging site
- RPK Pharmaceuticals, Inc., Union City, California, United States · repackages it and relabels it
Recalls
- Jan 21, 2025 · Class II · The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories
Failed impurities/degradation specifications and Sub-potent Drug: Out-of-specification results were obtained during routine stability testing for Assay and Impurities.
Lots: Lot #s: N01422, N01423, Exp 03/31/2025; N01661, N01662, Exp 09/30/2025; N01746, N01750, Exp 10/31/2025; N01876, N01877, Exp 03/31/2026; N01899, N01900, N01975, Exp 04/30/2026. - Sep 28, 2017 · Class II · Leading Pharma, LLC
Labeling: Label Error on Declared Strength. Bottle labeled as 0.5 mg tablets contained 1mg tablets of lorazepam
Lots: Lot #E00717
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Lorazepam: every company that makes it
- Form
- tablet
- Strength
- 2 mg
- Approval
- ANDA ANDA078203
- On the market since
- Oct 1, 2007
- Package NDCs
53002-6290-1- Official label
- DailyMed (National Library of Medicine), updated Jun 7, 2023
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?